Preoperative Chemoradiotherapy for Resectable Gastric Cancer

The addition of preoperative chemoradiotherapy to perioperative chemotherapy did not improve overall survival as compared with perioperative chemotherapy alone among patients with resectable gastric and gastroesophageal junction adenocarcinoma. (Funded by the National Health and Medical Research Council and others; TOPGEAR ClinicalTrials.gov number, NCT01924819.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-09-14
DOI
https://doi.org/10.1056/nejmoa2405195
Citations
86
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
36.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Rebecca Wong, David J. Willis, Alisha Moore, John Raymond Zalcberg et al.
86 citations
New England Journal of Medicine
Gastric Cancer Management and Outcomes
36.03
article

Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Rebecca Wong, David J. Willis, Alisha Moore, John Raymond Zalcberg, Chris J. O’Callaghan, Carol J. Swallow, B. Mark Smithers, Val Gebski, Rachel O’Connell, William K. Murray, Florian Lordick, Karin Haustermans, Danielle Miller, Gail Darling, Laurent Mineur, Michael Findlay, Alex Boussioutas, Michael Michael, Trevor Leong, Andrew Strickland, Moishe Liberman, John Simes
article en
86 citations

Abstract

The addition of preoperative chemoradiotherapy to perioperative chemotherapy did not improve overall survival as compared with perioperative chemotherapy alone among patients with resectable gastric and gastroesophageal junction adenocarcinoma. (Funded by the National Health and Medical Research Council and others; TOPGEAR ClinicalTrials.gov number, NCT01924819.).

New England Journal of MedicineVol. 391(19)
Peter MacCallum Cancer Centre (AU)
Cancer Australia, European Organisation for Research and Treatment of Cancer, Canadian Institutes of Health Research, Canadian Cancer Society Research Institute, National Health and Medical Research Council, Health Research Council of New Zealand
Openalex Percentile: Top 0%
Gastric Cancer Management and Outcomes
36.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.